Riboscience
Alan Jacobs is a highly experienced medical consultant and executive with a robust background in clinical development and regulatory affairs across various biotechnology firms. Currently serving as a Medical Consultant at Riboscience and Chief Medical Officer at New England Cell Therapeutics, Inc., Alan previously held leadership positions including Chief Medical Officer at Minovia Therapeutics and Aspire Health Science. Notable achievements include turning around a phase II clinical trial at Hemostemix, inventing the ScripClip™ system at PerceptiMed, and driving significant licensing deals during tenure at Perseid Professional Services. Alan holds advanced degrees in Electrical Engineering and a medical degree from the University of Pennsylvania, coupled with extensive experience in advancing innovative therapies in the fields of cell therapy and neurological disorders.
This person is not in any teams
Riboscience
Riboscience is a clinical stage biotechnology company developing treatments for serious infectious diseases and cancer. We apply ribose and structure-guided design technologies to the discovery of drugs that target proteins that are essential and unique to specific infectious pathogens, tumor cells or the anti-tumor immune response.